Jump to main content
Jump to site search

Issue 2, 2012
Previous Article Next Article

Development of second generation epigenetic agents

Author affiliations

Abstract

DNA in the nucleus of eukaryote cells is packaged in the nucleosomes around histone proteins, and this is highly organized and tightly regulated to control gene transcription. This packaging is not static and the histone tails undergo a wide variety of post-translational modifications that regulate gene transcription, and these patterns have been shown to be aberrantly regulated in multiple disease states. The biology behind these histone modifications is being elucidated, and it is now known that multiple proteins control the writing, reading and removal of these covalent histone modifications. The first agents, vorinostat and romidepsin, which inhibit histone deacetylase enzymes responsible for removing one of these marks have been approved for use in humans. This review focuses on the progress in the development of the second generation of epigenetic modifiers able to modulate histone marks, and restore normal gene transcription.

Graphical abstract: Development of second generation epigenetic agents

  • This article is part of the themed collection: Epigenetics
Back to tab navigation

Publication details

The article was received on 01 Aug 2011, accepted on 17 Sep 2011 and first published on 26 Oct 2011


Article type: Review Article
DOI: 10.1039/C1MD00199J
Citation: Med. Chem. Commun., 2012,3, 135-161
  •   Request permissions

    Development of second generation epigenetic agents

    P. Jones, Med. Chem. Commun., 2012, 3, 135
    DOI: 10.1039/C1MD00199J

Search articles by author

Spotlight

Advertisements